Ovation Science Engages CFN Enterprises Inc. to Reach a Broad Cannabis Investor Audience

Press Release

Ovation Science Inc. is a developer of cannabis-infused topicals, backed by patents and science and generating royalties through an out-licensing business model in the United States and international markets. Whitefish, Montana – (NewMediaWire) – March 16, 2021 – CFN Enterprises Inc.(OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced the addition of Ovation Science Inc.(CSE:OVAT) (OTCQB: OVATF) to its growing client roster. CFN Media will leverage its proprietary digital content platform and extensive distribution network—including its flagship CannabisFNwebsite—to attract targeted retail, accredited and institutional investors to Ovation Science Inc. “We are excited to be working with Ovation Science as it ramps up the commercialization of its cannabis-infused topicals,” said CFN Media President Frank Lane. “Topical cannabis products appeal to traditional cannabis users as well as non-traditional users exploring cannabis’ medicinal properties for the first time, and represent one of the industry’s fastest growing segments.” Ovation Science has developed a line of cannabis-infused topical products backed by over 20 years of research and development. Powered by its Invisicare® drug delivery technology, the company offers topicals that remain on the skin and transdermal creams that deliver CBD and THC through the skin and into the bloodstream. “We are excited to be working with CFN Media as they have an extensive network that targets the cannabis investment space,” said Terry Howlett, President & CEO of Ovation Science Inc.  “With our recent listing on the OTCQB, and the positive changes taking place in the cannabis industry in the USA, we engaged CFN Media as our partner to create greater awareness of Ovation’s products and achievements to their broad investment audience.” Topical cannabinoids have become increasingly popular over the past few years. Consumers have embraced the medicinal side of these products including their anti-inflammatory, anti-anxiety properties, even anti-aging benefits. About Ovation Science Inc. Ovation Science Inc. is a research and development company that develops topical and transdermal consumer products including its CBD/THC cannabis formulations including ARLO CBD Beauty and InVibe® MD (“health & wellness” line), and secondly, its unique DermSafe® hand sanitizer; all made with its patented Invisicare® skin delivery technology. The technology enhances the delivery of ingredients to and through the skin and is protected by patents in eleven countries. With over twenty years of topical and transdermal drug delivery experience in the pharmaceutical market, Ovation’s management and science team have created a unique pipeline of over twenty-five patent-protected medical / wellness topical and transdermal products along with a line of anti-aging / beauty formulas.  Ovation earns revenues from licensing and development fees, royalties, the sale of Invisicare to its licensees along with revenue from its own product sales.  Ovation has offices in Vancouver, BC, Canada and Las Vegas, Nevada, USA.  Ovation trades on the CSE under the symbol OVAT and in the USA on OTC Markets under the symbol OVATF.  Visit our website www.ovationscience.com for more information. About CFN Enterprises Inc. CFN Enterprises Inc. (OTCQB: CNFN) is a digital media and ecommerce company focused on advancing businesses and brands in highly regulated emerging industries across the globe. CFN connects investors with new market opportunities while helping consumers find innovative products that enhance their lives. Learn more at www.cfnenterprisesinc.com. CFN Enterprises Inc. Media Contact:CFN Enterprises Inc.+001 (833) 420-CNFN investors@cfnenterprisesinc.com FORWARD-LOOKING STATEMENTUse of Forward-looking StatementsThis press release may contain forward-looking statements from CFN Enterprises Inc. within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and federal …